Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Balance Sheet

Financials in millions JOD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.83	1.65	1.4	1.5	1.66
Cash & Short-Term Investments	1.83	1.65	1.4	1.5	1.66
Cash Growth	10.53%	18.11%	-6.64%	-9.82%	3.74%
Accounts Receivable	6.53	6.38	6.45	6.24	6.7
Other Receivables	-	-	-	0.07	0.07
Receivables	6.53	6.38	6.45	6.31	6.78
Inventory	2.27	1.9	1.89	1.42	1.66
Prepaid Expenses	-	0.16	0.18	0.14	0.11
Other Current Assets	0.51	0.15	0.19	0.03	0.03
Total Current Assets	11.13	10.24	10.12	9.39	10.24
Property, Plant & Equipment	2.83	2.88	2.06	2.29	2.39
Other Intangible Assets	3.26	-	-	-	2.44
Long-Term Deferred Charges	-	3.55	3.85	4.14	-
Total Assets	17.22	16.67	16.03	15.82	15.07
Accounts Payable	1.33	1.23	1.35	1.13	1.09
Accrued Expenses	0.01	0.14	0.24	0.28	0.22
Short-Term Debt	1.05	0.67	1.49	1.83	1.45
Current Portion of Long-Term Debt	-	0.48	-	-	-
Current Income Taxes Payable	0.27	0.14	0.13	0.1	0.08
Other Current Liabilities	0.32	0.14	0.06	0.09	0.11
Total Current Liabilities	2.99	2.79	3.28	3.44	2.94
Long-Term Debt	0.71	0.84	-	-	-
Total Liabilities	3.7	3.63	3.28	3.44	2.94
Common Stock	7.5	7.5	7.5	7.5	7.5
Retained Earnings	6.02	5.54	5.24	4.89	4.63
Shareholders' Equity	13.52	13.04	12.74	12.39	12.13
Total Liabilities & Equity	17.22	16.67	16.03	15.82	15.07
Total Debt	1.76	1.99	1.49	1.83	1.45
Net Cash (Debt)	0.07	-0.33	-0.09	-0.33	0.21
Net Cash Per Share	0.01	-0.04	-0.01	-0.04	0.03
Filing Date Shares Outstanding	7.5	7.5	7.5	7.5	7.5
Total Common Shares Outstanding	7.5	7.5	7.5	7.5	7.5
Working Capital	8.14	7.45	6.83	5.96	7.3
Book Value Per Share	1.80	1.74	1.70	1.65	1.62
Tangible Book Value	10.26	13.04	12.74	12.39	9.69
Tangible Book Value Per Share	1.37	1.74	1.70	1.65	1.29
Land	-	1.05	0.12	0.12	0.12
Buildings	-	1.64	1.6	1.59	1.59
Machinery	-	3.82	3.73	3.67	3.58

Source: S&P Global Market Intelligence. Standard template. Financial Sources.